NCT03035331 2025-05-16Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin LymphomaMayo ClinicPhase 1/2 Completed11 enrolled 12 charts
NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT02650999 2021-07-22Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory LymphomasAbramson Cancer Center at Penn MedicinePhase 1/2 Completed12 enrolled 8 charts
NCT02950220 2019-07-30Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaOhio State University Comprehensive Cancer CenterPhase 1 Completed2 enrolled